Recent Finacing
Recent Raise
Clarity Pharmaceuticals develops and commercializes PET radiopharmaceuticals and copper-radioisotope theranostics (SARTATE), provides PET-based companion diagnostics and radio‑immunotherapeutics, and offers imaging services for drug development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
